OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer
Lingping Kong, Fanlu Meng, Ping Zhou, et al.
Science Bulletin (2024) Vol. 69, Iss. 13, pp. 2122-2135
Open Access | Times Cited: 8

Showing 8 citing articles:

Targeted Degradation of HCV Polymerase by GalNAc-Conjugated ApTACs for Pan-Genotypic Antiviral Therapy with High Resistance Barriers
Wei Pan, Sijin Wu, Honglin Zhou, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Current developments of SELEX technologies and prospects in the aptamer selection with clinical applications
Danny CHINCHILLA-CÁRDENAS, Juan Sebastian Cruz-Méndez, Julieth Michel Petano-Duque, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 3, pp. 100400-100400
Open Access | Times Cited: 4

Targeted degradation of membrane and extracellular proteins with LYTACs
Yuyang Li, Yang Yang, Renshuai Zhang, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 4

Hydrophobic CPP/HDO Conjugates: A New Frontier in Oligonucleotide-Warheaded PROTAC Delivery
Miyako Naganuma, Nobumichi Ohoka, Motoharu Hirano, et al.
RSC Medicinal Chemistry (2024)
Closed Access

Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer
Nicoletta Cordani, Daniele Nova, Luca Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11214-11214
Open Access

Aptamer Proteolysis-Targeting Chimeras (PROTACs): A Novel Strategy to Combat Drug Resistance in Estrogen Receptor α-Positive Breast Cancer
Ying Feng, Zhilin Zhang, Haowei Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3945-3954
Open Access

Mutant p53-Mediated Tumor Secretome: Bridging Tumor Cells and Stromal Cells
Lei Qiu, Zelong Ma, Xiaoming Wu
Genes (2024) Vol. 15, Iss. 12, pp. 1615-1615
Open Access

Page 1

Scroll to top